BeiGene Newsroom

Jefferies Maintains BeiGene(BGNE.US) With Buy Rating, Maintains Target Price $286

Moomoo NewsDec 12 09:33 ET

Jefferies Maintains BeiGene(BGNE.US) With Buy Rating, Maintains Target Price $286

Moomoo NewsDec 12 08:31 ET

JMP Securities Maintains BeiGene(BGNE.US) With Buy Rating, Maintains Target Price $288

Moomoo NewsDec 11 10:31 ET

Jefferies Maintains BeiGene(BGNE.US) With Buy Rating, Raises Target Price to $286

Moomoo NewsDec 10 08:33 ET

Morgan Stanley Reaffirms Their Buy Rating on BeiGene (BGNE)

TipRanksDec 5 10:29 ET

BeiGene Analyst Ratings

BenzingaDec 3 08:59 ET

Morgan Stanley Assumes BeiGene at Overweight, Announces Price Target of $300

BenzingaDec 3 08:59 ET

Bernstein Maintains BeiGene(BGNE.US) With Hold Rating, Raises Target Price to $207

Moomoo NewsNov 29 12:32 ET

Analysts Offer Insights on Healthcare Companies: BeiGene (BGNE) and Teladoc (TDOC)

TipRanksNov 28 07:23 ET

BofA Securities Maintains BeiGene(BGNE.US) With Hold Rating, Raises Target Price to $207

Moomoo NewsNov 14 06:31 ET

BeiGene Is Maintained at Buy by TD Cowen

Dow JonesNov 13 13:12 ET

BeiGene Analyst Ratings

BenzingaNov 13 13:02 ET

TD Cowen Maintains BeiGene(BGNE.US) With Buy Rating, Maintains Target Price $260

Moomoo NewsNov 13 08:32 ET

JMP Securities Maintains BeiGene(BGNE.US) With Buy Rating, Maintains Target Price $288

Moomoo NewsNov 13 01:31 ET

TD Cowen Maintains BeiGene(BGNE.US) With Buy Rating, Raises Target Price to $260

Moomoo NewsNov 12 21:32 ET

BeiGene's Strong Performance and Promising Pipeline Drive Buy Rating

TipRanksNov 12 20:49 ET

JMP Securities Maintains BeiGene(BGNE.US) With Buy Rating, Maintains Target Price $288

Moomoo NewsNov 11 00:32 ET

BeiGene Is Maintained at Overweight by JP Morgan

Dow JonesOct 22 13:05 ET

BeiGene Analyst Ratings

BenzingaOct 22 12:56 ET

J.P. Morgan Maintains BeiGene(BGNE.US) With Buy Rating, Raises Target Price to $235

Moomoo NewsOct 22 07:35 ET